Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners

Cleveland Diagnostics

Other names: Cleveland Diagnostics | Cleveland_Dx
Related tests:


Cleveland Diagnostics Announces Agreement with Quest Diagnostics to Expand Patient Access to IsoPSA Prostate Cancer Testing (Businesswire)
"Cleveland Diagnostics, Inc...announced an agreement designed to expand patient access to Cleveland Diagnostics’ novel prostate cancer test, IsoPSA. Through an agreement with Quest Diagnostics...the nation’s leading provider of diagnostic information services, patients will be able to access IsoPSA and, once ordered by their physician, provide a blood specimen for testing at one of over 2,100 Quest Diagnostics patient service center locations nationwide later this year. With its national logistics network, Quest will transport the specimens to Cleveland Diagnostics’ laboratory for testing. The parties expect physicians will be able to begin offering the test to patients through Quest Diagnostics in the second quarter of 2023."
Licensing / partnership